Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Cell ; 152(5): 1008-20, 2013 Feb 28.
Article in English | MEDLINE | ID: mdl-23452850

ABSTRACT

Metazoan evolution involves increasing protein domain complexity, but how this relates to control of biological decisions remains uncertain. The Ras guanine nucleotide exchange factor (RasGEF) Sos1 and its adaptor Grb2 are multidomain proteins that couple fibroblast growth factor (FGF) signaling to activation of the Ras-Erk pathway during mammalian development and drive embryonic stem cells toward the primitive endoderm (PrE) lineage. We show that the ability of Sos1/Grb2 to appropriately regulate pluripotency and differentiation factors and to initiate PrE development requires collective binding of multiple Sos1/Grb2 domains to their protein and phospholipid ligands. This provides a cooperative system that only allows lineage commitment when all ligand-binding domains are occupied. Furthermore, our results indicate that the interaction domains of Sos1 and Grb2 have evolved so as to bind ligands not with maximal strength but with specificities and affinities that maintain cooperativity. This optimized system ensures that PrE lineage commitment occurs in a timely and selective manner during embryogenesis.


Subject(s)
Embryo, Mammalian/metabolism , Embryonic Stem Cells/metabolism , GRB2 Adaptor Protein/metabolism , SOS1 Protein/metabolism , Amino Acid Sequence , Animals , Cell Lineage , Endoderm/metabolism , Eukaryota/genetics , Eukaryota/metabolism , Humans , Models, Molecular , Molecular Sequence Data , Protein Structure, Tertiary , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/metabolism , Sequence Alignment , ras Guanine Nucleotide Exchange Factors/metabolism
2.
Cell ; 147(2): 306-19, 2011 Oct 14.
Article in English | MEDLINE | ID: mdl-22000011

ABSTRACT

Chronic myelogenous leukemia (CML) is caused by the constitutively active tyrosine kinase Bcr-Abl and treated with the tyrosine kinase inhibitor (TKI) imatinib. However, emerging TKI resistance prevents complete cure. Therefore, alternative strategies targeting regulatory modules of Bcr-Abl in addition to the kinase active site are strongly desirable. Here, we show that an intramolecular interaction between the SH2 and kinase domains in Bcr-Abl is both necessary and sufficient for high catalytic activity of the enzyme. Disruption of this interface led to inhibition of downstream events critical for CML signaling and, importantly, completely abolished leukemia formation in mice. Furthermore, disruption of the SH2-kinase interface increased sensitivity of imatinib-resistant Bcr-Abl mutants to TKI inhibition. An engineered Abl SH2-binding fibronectin type III monobody inhibited Bcr-Abl kinase activity both in vitro and in primary CML cells, where it induced apoptosis. This work validates the SH2-kinase interface as an allosteric target for therapeutic intervention.


Subject(s)
Fusion Proteins, bcr-abl/antagonists & inhibitors , Fusion Proteins, bcr-abl/chemistry , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/enzymology , Protein-Tyrosine Kinases/antagonists & inhibitors , Protein-Tyrosine Kinases/chemistry , Amino Acid Sequence , Animals , Base Sequence , Benzamides , Cells, Cultured , Fusion Proteins, bcr-abl/metabolism , Humans , Imatinib Mesylate , Isoleucine/metabolism , Mice , Models, Molecular , Molecular Sequence Data , Piperazines/pharmacology , Protein Kinase Inhibitors/pharmacology , Protein-Tyrosine Kinases/metabolism , Pyrimidines/pharmacology , Signal Transduction , src Homology Domains
3.
Mol Cell ; 70(6): 995-1007.e11, 2018 06 21.
Article in English | MEDLINE | ID: mdl-29910111

ABSTRACT

Phosphotyrosine (pTyr) signaling has evolved into a key cell-to-cell communication system. Activated receptor tyrosine kinases (RTKs) initiate several pTyr-dependent signaling networks by creating the docking sites required for the assembly of protein complexes. However, the mechanisms leading to network disassembly and its consequence on signal transduction remain essentially unknown. We show that activated RTKs terminate downstream signaling via the direct phosphorylation of an evolutionarily conserved Tyr present in most SRC homology (SH) 3 domains, which are often part of key hub proteins for RTK-dependent signaling. We demonstrate that the direct EPHA4 RTK phosphorylation of adaptor protein NCK SH3s at these sites results in the collapse of signaling networks and abrogates their function. We also reveal that this negative regulation mechanism is shared by other RTKs. Our findings uncover a conserved mechanism through which RTKs rapidly and reversibly terminate downstream signaling while remaining in a catalytically active state on the plasma membrane.


Subject(s)
Receptor Protein-Tyrosine Kinases/physiology , Receptor, EphA4/metabolism , src Homology Domains/physiology , Adaptor Proteins, Signal Transducing/metabolism , Amino Acid Sequence , Animals , Cell Communication , Drosophila/metabolism , HEK293 Cells , HeLa Cells , Humans , Ligands , Oncogene Proteins/metabolism , Phosphorylation , Phosphotyrosine/metabolism , Protein Binding , Receptor Protein-Tyrosine Kinases/metabolism , Signal Transduction/physiology , Tyrosine/metabolism
4.
Cell ; 134(5): 793-803, 2008 Sep 05.
Article in English | MEDLINE | ID: mdl-18775312

ABSTRACT

The SH2 domain of cytoplasmic tyrosine kinases can enhance catalytic activity and substrate recognition, but the molecular mechanisms by which this is achieved are poorly understood. We have solved the structure of the prototypic SH2-kinase unit of the human Fes tyrosine kinase, which appears specialized for positive signaling. In its active conformation, the SH2 domain tightly interacts with the kinase N-terminal lobe and positions the kinase alphaC helix in an active configuration through essential packing and electrostatic interactions. This interaction is stabilized by ligand binding to the SH2 domain. Our data indicate that Fes kinase activation is closely coupled to substrate recognition through cooperative SH2-kinase-substrate interactions. Similarly, we find that the SH2 domain of the active Abl kinase stimulates catalytic activity and substrate phosphorylation through a distinct SH2-kinase interface. Thus, the SH2 and catalytic domains of active Fes and Abl pro-oncogenic kinases form integrated structures essential for effective tyrosine kinase signaling.


Subject(s)
Proto-Oncogene Proteins c-abl/chemistry , Proto-Oncogene Proteins c-fes/chemistry , Amino Acid Sequence , Crystallography, X-Ray , Enzyme Activation , Humans , Ligands , Models, Molecular , Molecular Sequence Data , Protein Interaction Domains and Motifs , Protein Structure, Tertiary , Proto-Oncogene Proteins c-abl/metabolism , Proto-Oncogene Proteins c-fes/metabolism
5.
Mol Cell ; 59(6): 970-83, 2015 Sep 17.
Article in English | MEDLINE | ID: mdl-26344097

ABSTRACT

BRCC36 is a Zn(2+)-dependent deubiquitinating enzyme (DUB) that hydrolyzes lysine-63-linked ubiquitin chains as part of distinct macromolecular complexes that participate in either interferon signaling or DNA-damage recognition. The MPN(+) domain protein BRCC36 associates with pseudo DUB MPN(-) proteins KIAA0157 or Abraxas, which are essential for BRCC36 enzymatic activity. To understand the basis for BRCC36 regulation, we have solved the structure of an active BRCC36-KIAA0157 heterodimer and an inactive BRCC36 homodimer. Structural and functional characterizations show how BRCC36 is switched to an active conformation by contacts with KIAA0157. Higher-order association of BRCC36 and KIAA0157 into a dimer of heterodimers (super dimers) was required for DUB activity and interaction with targeting proteins SHMT2 and RAP80. These data provide an explanation of how an inactive pseudo DUB allosterically activates a cognate DUB partner and implicates super dimerization as a new regulatory mechanism underlying BRCC36 DUB activity, subcellular localization, and biological function.


Subject(s)
Ants/enzymology , Insect Proteins/chemistry , Nuclear Matrix-Associated Proteins/chemistry , Ubiquitin-Specific Proteases/chemistry , Animals , Catalytic Domain , Crystallography, X-Ray , Deubiquitinating Enzymes , HEK293 Cells , HeLa Cells , Humans , Insect Proteins/physiology , Kinetics , Membrane Proteins/chemistry , Models, Molecular , Nuclear Matrix-Associated Proteins/physiology , Protein Binding , Protein Multimerization , Protein Structure, Quaternary , Protein Structure, Secondary , Ubiquitin-Specific Proteases/physiology
6.
Mol Cell ; 54(6): 1034-1041, 2014 Jun 19.
Article in English | MEDLINE | ID: mdl-24910098

ABSTRACT

Cell signaling depends on dynamic protein-protein interaction (PPI) networks, often assembled through modular domains each interacting with multiple peptide motifs. This complexity raises a conceptual challenge, namely to define whether a particular cellular response requires assembly of the complete PPI network of interest or can be driven by a specific interaction. To address this issue, we designed variants of the Grb2 SH2 domain ("pY-clamps") whose specificity is highly biased toward a single phosphotyrosine (pY) motif among many potential pYXNX Grb2-binding sites. Surprisingly, directing Grb2 predominantly to a single pY site of the Ptpn11/Shp2 phosphatase, but not other sites tested, was sufficient for differentiation of the essential primitive endoderm lineage from embryonic stem cells. Our data suggest that discrete connections within complex PPI networks can underpin regulation of particular biological events. We propose that this directed wiring approach will be of general utility in functionally annotating specific PPIs.


Subject(s)
Cell Differentiation , Embryonic Stem Cells/cytology , GRB2 Adaptor Protein/metabolism , Protein Interaction Maps/genetics , Protein Tyrosine Phosphatase, Non-Receptor Type 11/metabolism , Animals , Binding Sites/genetics , Cell Differentiation/genetics , Cell Line , Crystallography, X-Ray , Embryonic Stem Cells/metabolism , Fibroblast Growth Factor 4/metabolism , GRB2 Adaptor Protein/genetics , Mice , Models, Molecular , Protein Binding/genetics , Protein Structure, Tertiary , Protein Tyrosine Phosphatase, Non-Receptor Type 11/genetics , Protein Tyrosine Phosphatase, Non-Receptor Type 11/ultrastructure , Signal Transduction/genetics
7.
J Biol Chem ; 295(12): 3932-3944, 2020 03 20.
Article in English | MEDLINE | ID: mdl-32060095

ABSTRACT

Eph receptors are a family of receptor tyrosine kinases that control directional cell movement during various biological processes, including embryogenesis, neuronal pathfinding, and tumor formation. The biochemical pathways of Eph receptors are context-dependent in part because of the varied composition of a heterotypic, oligomeric, active Eph receptor complex. Downstream of the Eph receptors, little is known about the essential phosphorylation events that define the context and instruct cell movement. Here, we define a pathway that is required for Eph receptor B2 (EphB2)-mediated cell sorting and is conserved among multiple Eph receptors. Utilizing a HEK293 model of EphB2+/ephrinB1+ cell segregation, we found that the scaffold adaptor protein SH2 domain-containing adaptor protein B (Shb) is essential for EphB2 functionality. Further characterization revealed that Shb interacts with known modulators of cytoskeletal rearrangement and cell mobility, including Nck adaptor protein (Nck), p120-Ras GTPase-activating protein (RasGAP), and the α- and ß-Chimaerin Rac GAPs. We noted that phosphorylation of Tyr297, Tyr246, and Tyr336 of Shb is required for EphB2-ephrinB1 boundary formation, as well as binding of Nck, RasGAP, and the chimaerins, respectively. Similar complexes were formed in the context of EphA4, EphA8, EphB2, and EphB4 receptor activation. These results indicate that phosphotyrosine-mediated signaling through Shb is essential in EphB2-mediated heterotypic cell segregation and suggest a conserved function for Shb downstream of multiple Eph receptors.


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , Chimerin Proteins/metabolism , Oncogene Proteins/metabolism , Proto-Oncogene Proteins/metabolism , RNA-Binding Proteins/metabolism , Receptor, EphB2/metabolism , Adaptor Proteins, Signal Transducing/antagonists & inhibitors , Adaptor Proteins, Signal Transducing/chemistry , Adaptor Proteins, Signal Transducing/genetics , Cell Separation , Chimerin Proteins/chemistry , Ephrin-B1/genetics , Ephrin-B1/metabolism , HEK293 Cells , Humans , Mass Spectrometry , Oncogene Proteins/chemistry , Phosphorylation , Protein Binding , Protein Subunits/chemistry , Protein Subunits/metabolism , Proto-Oncogene Proteins/antagonists & inhibitors , Proto-Oncogene Proteins/genetics , RNA Interference , RNA, Small Interfering/metabolism , RNA-Binding Proteins/chemistry , Receptor, EphB2/chemistry , Receptor, EphB2/genetics , Signal Transduction , src Homology Domains
8.
Proc Natl Acad Sci U S A ; 112(13): E1594-603, 2015 Mar 31.
Article in English | MEDLINE | ID: mdl-25829543

ABSTRACT

Systematic characterization of intercellular signaling approximating the physiological conditions of stimulation that involve direct cell-cell contact is challenging. We describe a proteomic strategy to analyze physiological signaling mediated by the T-cell costimulatory receptor CD28. We identified signaling pathways activated by CD28 during direct cell-cell contact by global analysis of protein phosphorylation. To define immediate CD28 targets, we used phosphorylated forms of the CD28 cytoplasmic region to obtain the CD28 interactome. The interaction profiles of selected CD28-interacting proteins were further characterized in vivo for amplifying the CD28 interactome. The combination of the global phosphorylation and interactome analyses revealed broad regulation of CD28 and its interactome by phosphorylation. Among the cellular phosphoproteins influenced by CD28 signaling, CapZ-interacting protein (CapZIP), a regulator of the actin cytoskeleton, was implicated by functional studies. The combinatorial approach applied herein is widely applicable for characterizing signaling networks associated with membrane receptors with short cytoplasmic tails.


Subject(s)
CD28 Antigens/metabolism , Cell Communication , Gene Expression Regulation , Receptors, Peptide/metabolism , Actins/metabolism , Cell Line, Tumor , Cytoskeleton/metabolism , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Humans , Intracellular Signaling Peptides and Proteins/metabolism , Jurkat Cells , Mass Spectrometry , Phosphoproteins/metabolism , Phosphorylation , Protein Binding , Protein Structure, Tertiary , Proteomics , Signal Transduction
9.
Nat Commun ; 12(1): 1597, 2021 03 12.
Article in English | MEDLINE | ID: mdl-33712617

ABSTRACT

Protein-protein interactions (PPIs) between modular binding domains and their target peptide motifs are thought to largely depend on the intrinsic binding specificities of the domains. The large family of SRC Homology 3 (SH3) domains contribute to cellular processes via their ability to support such PPIs. While the intrinsic binding specificities of SH3 domains have been studied in vitro, whether each domain is necessary and sufficient to define PPI specificity in vivo is largely unknown. Here, by combining deletion, mutation, swapping and shuffling of SH3 domains and measurements of their impact on protein interactions in yeast, we find that most SH3s do not dictate PPI specificity independently from their host protein in vivo. We show that the identity of the host protein and the position of the SH3 domains within their host are critical for PPI specificity, for cellular functions and for key biophysical processes such as phase separation. Our work demonstrates the importance of the interplay between a modular PPI domain such as SH3 and its host protein in establishing specificity to wire PPI networks. These findings will aid understanding how protein networks are rewired during evolution and in the context of mutation-driven diseases such as cancer.


Subject(s)
Protein Interaction Maps , Proteins/chemistry , src Homology Domains , HEK293 Cells , Humans , Protein Interaction Domains and Motifs , Proteins/metabolism , Saccharomyces cerevisiae/metabolism , src Homology Domains/genetics
10.
Protein Sci ; 28(5): 848-856, 2019 05.
Article in English | MEDLINE | ID: mdl-30793400

ABSTRACT

We previously described structural and functional characterization of the first ubiquitin variant (UbV), UbV.v27.1, engineered by phage display to bind with high affinity to a specific ubiquitin interacting motif (UIM). We identified two substitutions relative to ubiquitin (Gly10Val/His68Tyr) that were critical for enhancing binding affinity but could only rationalize the mechanism of action of the Tyr68 substitution. Here, we extend our characterization and uncover the mechanism by which the Val10 substitution enhances binding affinity. We show that Val10 in UbV.v27.1 drives UbV dimerization through an intermolecular ß-strand exchange. Dimerization serves to increase the contact surface between the UIM and UbV and also affords direct contacts between two UIMs through an overall 2:2 binding stoichiometry. Our identification of the role of Val10 in UbV dimerization suggests a general means for the development of dimeric UbVs with improved affinity and specificity relative to their monomeric UbV counterparts. Statement: Previously, we used phage display to engineer a UbV that bound tightly and specifically to a UIM. Here, we discovered that tight binding is partly due to the dimerization of the UbV, which increases the contact surface between the UbV and UIM. We show that UbV dimerization is dependent on the Gly10Val substitution, and posit that dimerization may provide a general means for engineering UbVs with improved binding properties.


Subject(s)
Ubiquitin/chemistry , Ubiquitin/genetics , Valine/genetics , Amino Acid Substitution , Binding Sites , Cell Surface Display Techniques , Humans , Models, Molecular , Protein Binding , Protein Engineering , Protein Multimerization , Protein Structure, Secondary
11.
Mol Cell Biol ; 34(2): 246-58, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24216761

ABSTRACT

Casein kinase 2 (CK2) regulates multiple cellular processes and can promote oncogenesis. Interactions with the CK2ß regulatory subunit of the enzyme target its catalytic subunit (CK2α or CK2α') to specific substrates; however, little is known about the mechanisms by which these interactions occur. We previously showed that by binding CK2ß, the Epstein-Barr virus (EBV) EBNA1 protein recruits CK2 to promyelocytic leukemia (PML) nuclear bodies, where increased CK2-mediated phosphorylation of PML proteins triggers their degradation. Here we have identified a KSSR motif near the dimerization interface of CK2ß as forming part of a protein interaction pocket that mediates interaction with EBNA1. We show that the EBNA1-CK2ß interaction is primed by phosphorylation of EBNA1 on S393 (within a polyserine region). This phosphoserine is critical for EBNA1-induced PML degradation but does not affect EBNA1 functions in EBV replication or segregation. Using comparative proteomics of wild-type (WT) and KSSR mutant CK2ß, we identified an uncharacterized cellular protein, C18orf25/ARKL1, that also binds CK2ß through the KSSR motif and show that this involves a polyserine sequence resembling the CK2ß binding sequence in EBNA1. Therefore, we have identified a new mechanism of CK2 interaction used by viral and cellular proteins.


Subject(s)
Carrier Proteins/metabolism , Casein Kinase II/metabolism , Epstein-Barr Virus Nuclear Antigens/metabolism , Active Transport, Cell Nucleus , Adaptor Proteins, Signal Transducing , Amino Acid Sequence , Amino Acid Substitution , Binding Sites , Casein Kinase II/chemistry , Cell Line, Tumor , Cell Nucleus/metabolism , Epstein-Barr Virus Nuclear Antigens/genetics , HEK293 Cells , Humans , Models, Molecular , Molecular Sequence Data , Mutagenesis, Site-Directed , Phosphorylation , Protein Binding , Protein Interaction Domains and Motifs , Protein Interaction Mapping , Protein Processing, Post-Translational , Protein Structure, Secondary
12.
Sci Signal ; 5(226): ra39, 2012 May 29.
Article in English | MEDLINE | ID: mdl-22649097

ABSTRACT

Ankyrin repeat family A protein 2 (ANKRA2) interacts with the plasma membrane receptor megalin and the class IIa histone deacetylases HDAC4 and HDAC5. We report that the ankyrin repeat domains of ANKRA2 and its close paralog regulatory factor X-associated ankyrin-containing protein (RFXANK) recognize a PxLPxI/L motif found in diverse binding proteins, including HDAC4, HDAC5, HDAC9, megalin, and regulatory factor X, 5 (RFX5). Crystal structures of the ankyrin repeat domain of ANKRA2 in complex with its binding peptides revealed that each of the middle three ankyrin repeats of ANKRA2 recognizes a residue from the PxLPxI/L motif in a tumbler-lock binding mode, with ANKRA2 acting as the lock and the linear binding motif serving as the key. Structural analysis showed that three disease-causing mutations in RFXANK affect residues that are critical for binding to RFX5. These results suggest a fundamental principle of longitudinal recognition of linear sequences by a repeat-type domain. In addition, phosphorylation of serine 350, a residue embedded within the PxLPxI/L motif of HDAC4, impaired the binding of ANKRA2 but generated a high-affinity docking site for 14-3-3 proteins, which may help sequester this HDAC in the cytoplasm. Thus, the binding preference of the PxLPxI/L motif is signal-dependent. Furthermore, proteome-wide screening suggested that a similar phosphorylation-dependent switch may operate in other pathways. Together, our findings uncover a previously uncharacterized sequence- and signal-dependent peptide recognition mode for a repeat-type protein domain.


Subject(s)
Ankyrin Repeat/physiology , Ankyrins/chemistry , Ankyrins/metabolism , 14-3-3 Proteins/chemistry , 14-3-3 Proteins/genetics , 14-3-3 Proteins/metabolism , Ankyrins/genetics , DNA-Binding Proteins/chemistry , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , HEK293 Cells , Histone Deacetylases/chemistry , Histone Deacetylases/genetics , Histone Deacetylases/metabolism , Humans , Mutation , Protein Binding , Regulatory Factor X Transcription Factors , Repressor Proteins/chemistry , Repressor Proteins/genetics , Repressor Proteins/metabolism , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL